Navamedic ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	565.36	531.44	512	382.14	278.44
Revenue Growth (YoY)	6.38%	3.80%	33.98%	37.24%	32.67%
Cost of Revenue	345.04	325.92	313.63	218.62	166.7
Gross Profit	220.32	205.52	198.37	163.52	111.74
Selling, General & Admin	172.71	70.26	63.67	48.09	44.46
Amortization of Goodwill & Intangibles	27.19	10.49	8.61	4.85	4.55
Other Operating Expenses	-	88.7	83.13	63.75	49.12
Operating Expenses	204.07	173.72	158.73	119.08	100.29
Operating Income	16.25	31.8	39.64	44.45	11.46
Interest Expense	-28.06	-10.01	-7.77	-0.61	-2.5
Interest & Investment Income	-	3.1	4.63	3.08	2.79
Earnings From Equity Investments	-	-	-	-1.1	-3.19
Currency Exchange Gain (Loss)	-	-6.28	5.94	-9.24	-5.52
Other Non Operating Income (Expenses)	-	6.91	-6.43	13.58	-0.68
EBT Excluding Unusual Items	-11.81	25.52	36.01	50.15	2.36
Merger & Restructuring Charges	-3.85	-	-16.06	-	-
Gain (Loss) on Sale of Investments	-	-1.55	-8.7	-7.64	-
Other Unusual Items	-	-25.59	-17.4	-	-
Pretax Income	-15.66	-1.62	-6.16	42.51	2.36
Income Tax Expense	7.88	3.87	7.53	13.07	1.74
Earnings From Continuing Operations	-23.54	-5.49	-13.69	29.43	0.62
Net Income	-23.54	-5.49	-13.69	29.43	0.62
Net Income to Common	-23.54	-5.49	-13.69	29.43	0.62
Net Income Growth	-	-	-	4662.46%	-
Shares Outstanding (Basic)	-	17	17	17	16
Shares Outstanding (Diluted)	-	17	17	17	16
Shares Change (YoY)	-	1.24%	1.48%	3.60%	13.61%
EPS (Basic)	-	-0.31	-0.79	1.75	0.04
EPS (Diluted)	-	-0.31	-0.79	1.73	0.04
EPS Growth	-	-	-	4459.36%	-
Free Cash Flow	24.19	36.03	-0.02	15.69	-2.02
Free Cash Flow Per Share	-	2.06	-0.00	0.92	-0.12
Gross Margin	38.97%	38.67%	38.74%	42.79%	40.13%
Operating Margin	2.88%	5.98%	7.74%	11.63%	4.11%
Profit Margin	-4.16%	-1.03%	-2.67%	7.70%	0.22%
Free Cash Flow Margin	4.28%	6.78%	-0.00%	4.11%	-0.73%
EBITDA	47.61	43.46	49.16	49.62	16.15
EBITDA Margin	8.42%	8.18%	9.60%	12.99%	5.80%
D&A For EBITDA	31.36	11.66	9.52	5.18	4.69
EBIT	16.25	31.8	39.64	44.45	11.46
EBIT Margin	2.88%	5.98%	7.74%	11.63%	4.11%
Effective Tax Rate	-	-	-	30.76%	73.79%
Revenue as Reported	-	531.44	512	382.14	278.44

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.